ArticleJournal of psychiatric research2021
What have we learned in the past year? A study on pharmacy purchases of psychiatric drugs from wholesalers in the days prior to the first and second COVID-19 lockdowns in Germany.
Article in Journal of psychiatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Novel Green Lithium Oxide Nanoparticle for Adsorption of the Escitalopram Oxalate andACS omega · 2025Article
- Environmental concerns and bioaccumulation of psychiatric drugs in water bodies - Conventional versus biocatalytic systems of mitigation.Environmental research · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
No study has yet investigated how the second coronavirus disease (COVID-19) lockdown has impacted the consumption of psychiatric medications in Germany. Therefore, the goal of this study was to analyze weekly pharmacy purchases of psychiatric drugs from wholesalers in this country in 2019 and 2020 using data from the IMS RPM® (Regional Pharmaceutical Market) Weekly Database. The outcome was the number of pharmacy purchases of psychiatric drugs per week from wholesalers between Calendar Week 2 and Calendar Week 52 in 2019 and 2020. Calendar Weeks 12 and 51 in 2020 corresponded to the days prior to the first and second German COVID-19 lockdowns, respectively. Descriptively, compared with 2019, the number of weekly pharmacy purchases of psychiatric drugs increased by 32% between Calendar Weeks 2-11 and Calendar Week 12 in 2020, while there was a 9% increase between Calendar Weeks 13-50 and Calendar Week 51 that same year. Overall, the relative increase in the weekly pharmacy purchases of psychiatric drugs from wholesalers was less pronounced before the second COVID-19 lockdown in Germany than before the first. Further studies are warranted to identify factors (e.g., decreases in panic buying) that may have contributed to this decreasing trend.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.